Oral sustained delivery of atenolol from floating matrix tablets - Formulation and in vitro evaluation

Drug Development and Industrial Pharmacy

Volumn 31, Issue 4-5, 2005, Pages 367-374

  Srivastava, A K ^a   Wadhwa, Saurabh ^a   Ridhurkar, D ^a   Mishra, B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Atenolol; Floating matrix; Guargum; HPMC; Swelling index

Indexed keywords

ATENOLOL; CARBOXYMETHYLCELLULOSE; GUAR GUM; HYDROXYMETHYLCELLULOSE; POLYMER;

ARTICLE; COMPRESSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; FLOATING MATRIX TABLET; IN VITRO STUDY; LINEAR REGRESSION ANALYSIS; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; TABLET; TABLET FORMULATION; TABLET HARDNESS; TABLET PROPERTY; TABLET THICKNESS;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CARBOXYMETHYLCELLULOSE; DELAYED-ACTION PREPARATIONS; HARDNESS; METHYLCELLULOSE; POROSITY; SURFACE TENSION; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 24744462904     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1081/DDC-54313     Document Type: Article

References (17)

1. Amidon, G. L., Lennernas, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailabitlity. Pharmaceutical Research, 12, 413-420.
2. Baumgartner, S., Smid-Korber, J., Vreces, F., & Kristl, J. (1998). Physical and technological parameters influencing floating properties of matrix tablets based on cellulose ethers. STP Pharma Sciences, 8, 182-187.
3. Baumgartner, S., Kriste, J., & Zorko, B. (2000). Optimization of floating matrix tablets and evaluation of their gastric residence time. International Journal of Pharmaceutics, 195, 125-135.
4. Brahma, N., & Kwon, H. K. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. Journal of Controlled Release, 63, 235-259.
5. Davis, D. W. (1968, December 31). Method of Swallowing a Pill. US Patent 3,418,999.
6. Desai, S., & Bolton, S. (1993). A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharmaceutical Research, 10, 1321-1325.
7. Deshpande, A. A., Rhodes, C. T., Shah, N. H., & Malick, A. W. (1996). Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Development and Industrial Pharmacy, 22, 531-539.
8. Hwang, S. J., Park, H., & Park, K. (1998). Gastric retentive drug-delivery systems. Critical Reviews in Therapeutic Drug, 15, 243-284.
9. Melander, A., Stenberg, P., Liedholm, H., Schersten, B., & Wahlin-Boll, E. (1979). Food induced reduction in bioavailability of atenolol. European Journal of Clinical Pharmacology, 16, 327-330.
10. Michaels, A. S. (1979, January 22). Drug Delivery Device with Self Actuated Mechanism for Retaining Device in Selected Area. US Patent 3,786,813.
11. Oth, M., Franz, M., Timmermans, J., & Moes, A. (1992). The bilayer floating capsule: a stomach-directed drug delivery system for Misoprostol. Pharmaceutical Research, 9, 298-302.
12. Rouge, N., Allermann, E., Gex-Fabry, M., Balant, L., Cole, E. T., Buri, P., & Doelker, E. (1998). Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharmaceutica Acta Helvetiae, 73, 81-87.
13. Sheth, P. R., & Tossounian, J. (1978, November 21). Sustained Release Pharmaceutical Capsules. US Patent 4,126,672.
14. Sheth, P. R., & Tossounian, J. L. (1979, September 11). Novel Sustained Release Tablet Formulations. US Patent 4,167,558.
15. Sheth, P. R., & Tossounian, J. (1994). The hydrodynamically balanced system (HBS): a novel drug delivery system for oral use. Drug Development and Industrial Pharmacy, 20, 313-339.
16. Timmermans, J., & Moes, A. J. (1990). How well do floating dosage forms float? International Journal of Pharmaceutics, 62, 207-216.
17. Watanabe, S., Kayano, M., Ishino, Y., & Miyao, K. (1976, August 24). Solid Therapeutic Preparation Remaining in Stomach. US Patent 3,976,764.